After anticipation of integrating two health systems for the last two years, Essentia Health and Marshfield Clinic Health System (MCHS) recently announced their merger will no longer be in effect.
© Anelo - stock.adobe.com
After anticipation of integrating two health systems for the last two years, Essentia Health and Marshfield Clinic Health System (MCHS) recently announced their merger will no longer be in effect.
Shared in a press release last week, the two health systems decided their merger was not the right move to take at this time in respect of their organizations, colleagues and patients.
Essentia Health, a Minnesota-based health system, serves patients in not only in their home state but in Wisconsin and North Dakota.
MCHS is based in Wisconsin and serves Wisconsin residents and Michigan’s Upper Peninsula.
The health systems shared they would continue to collaborate with each other, but as separate organizations that are "dedicated to sustainable rural healthcare."
In a joint statement they shared they “have great respect for one another, and we each remain committed to strengthening the health of our communities as we deliver high-quality, compassionate patient care.”
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More